Skip to main content

Table 5 Drug classes, changes in utilisation and annual prices

From: Modelling the cost-effectiveness of pay-for-performance in primary care in the UK

Drug classa

DDD/PU/mob

Annual pricec

Lipid regulating drugs

1.92

61.57

Renin angiotensin

0.84

37.29

Thiazides/diuretics

0.24

5.66

Oral antidiabetic

0.14

42.79

Antiplatelet

0.33

14.77

  1. DDD defined daily dose, mo month, PU prescribing unit, QOF Quality and Outcomes Framework
  2. aCardiovascular disease drug classes from MacBride-Stewart et al. [29]
  3. bIncrease in defined daily doses (DDDs) per prescribing unit (PU) per month of QOF-related drugs
  4. cWeighted average price (weights based on quantity dispensed by specific drugs and doses)
  5. (source: Health and Social Care Information Centre. Prescription cost analysis, England 2012)
  6. https://digital.nhs.uk/data-and-information/publications/statistical/prescription-cost-analysis/prescription-cost-analysis-england-2012
Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us